MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings. The recall affects approximately 3 million sensors and was caused by an ...

DexCom has had a rough ride this year. The medical technology company is grappling with concerns about its slowing growth and allegations of faulty blood glucose monitors. However, DexCom is “already ...

Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.

To pair any controller with the Switch 2 you’ll need the console powered on and updated to the latest system software.

Airlines often blame weather for delays. Here’s how to use ExpertFlyer to see the real reason your flight was delayed or ...

Wondering if DexCom stock is a hidden bargain or just riding a wave? You are not alone, and today's market swings only add to the intrigue. DexCom shares have jumped 5.4% over the past week even after ...

Google changed the Pixel’s home screen search UI, but there’s a simple way to bring the old search experience back. Here's how to do it.

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 10.25% on an annualized basis producing an average annual return of 22.3%. Currently, DexCom has a market capitalization of ...

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. DexCom made certain product changes without FDA authorization. The Company's product changes ...

DexCom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of Dexcom Academy, a new personalised learning ...